These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6357257)

  • 21. The combination of prazosin and verapamil in the treatment of essential hypertension.
    Elliott HL; Meredith PA; Campbell L; Reid JL
    Clin Pharmacol Ther; 1988 May; 43(5):554-60. PubMed ID: 3284690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of an autorhythmometric experimental design to achieve individual adjustment of antihypertensive treatment.
    Romano S; Gizdulich P; Scarpelli PT
    Methods Find Exp Clin Pharmacol; 1981; 3(4):223-31. PubMed ID: 7024688
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.
    Ramsay LE; Parnell L; Waller PC
    Postgrad Med J; 1987 Feb; 63(736):99-103. PubMed ID: 3671250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
    Hua AS; Macdonald IM; Myers JB; Fang P; Kincaid-Smith P
    Med J Aust; 1977 Jul; 2(1):5-9. PubMed ID: 331040
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
    Pape J
    Acta Med Scand Suppl; 1974; 554():55-62. PubMed ID: 4593674
    [No Abstract]   [Full Text] [Related]  

  • 26. Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Sep; 14(3):163-97. PubMed ID: 143363
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
    Melkild A
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):148-49. PubMed ID: 6992338
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydralazine once daily in hypertension.
    Silas JH; Ramsay LE; Freestone S
    Br Med J (Clin Res Ed); 1982 May; 284(6329):1602-4. PubMed ID: 6805621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Essential hypertension with single daily doses of a prazosin-polythiazide combination: a multicentre study with Minizide.
    Gordon AJ; Woeltjen AE
    J Int Med Res; 1981; 9(5):303-8. PubMed ID: 7297754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of single dose of prazosin on the indicators of central hemodynamics].
    Raĭbart IaIa; Kruglov RL; Bogdanovich AR
    Kardiologiia; 1984 Feb; 24(2):115-6. PubMed ID: 6716767
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of hypotensive and hemodynamic effects of prazosin in patients with hypertension].
    Ostapiuk FE; Dobrotvorskaia TE; Samofanova MS; Shengeliia RG
    Kardiologiia; 1986 Mar; 26(3):45-9. PubMed ID: 3520086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
    McAreavey D; Ramsey LE; Latham L; McLaren AD; Lorimer AR; Reid JL; Robertson JI; Robertson MP; Weir RJ
    Br Med J (Clin Res Ed); 1984 Jan; 288(6411):106-11. PubMed ID: 6419809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peripheral vasodilators in the treatment of hypertension. A review].
    Rasmussen K
    Ugeskr Laeger; 1979 Jan; 141(5):312-4. PubMed ID: 760314
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined central and peripheral sympathetic blockade: absence of additive antihypertensive effects.
    Hubbell FA; Weber MA; Drayer JI; Rose DE
    Am J Med Sci; 1983; 285(2):18-26. PubMed ID: 6837621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term antihypertensive treatment with prazosin in combination with a diuretic].
    Okun R; Maxwell M
    Cardiology; 1980; 66 Suppl 2():111-7. PubMed ID: 7285022
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of once daily hydralazine in inadequately controlled hypertension.
    Danielson M; Kjellberg J; Ohman P; Wernersson B
    Acta Med Scand; 1983; 214(5):373-80. PubMed ID: 6362341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in effect of low doses of prozosin in hypertensive Nigerians.
    Oviasu OV; Idahosa PE
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):757-62. PubMed ID: 827422
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical trial of a new antihypertensive combination: prazosin and polythiazide].
    Fischer DM; Casanova R
    Clin Ter; 1976 Sep; 78(6):559-73. PubMed ID: 797508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.